Ascendis Pharma Cash from Investing (TTM) Analysis

Ascendis Pharma A/S (ASND)

137.00 -6.18 (-4.32%) USD | NASDAQ | Apr 25, 16:00

137.00 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	310.14M
September 30, 2023	306.78M
June 30, 2023	294.42M
March 31, 2023	248.10M
December 31, 2022	65.10M
September 30, 2022	-69.43M
June 30, 2022	-56.25M
March 31, 2022	-51.29M
December 31, 2021	-130.83M
September 30, 2021	-73.63M
June 30, 2021	-86.30M
March 31, 2021	-362.07M
December 31, 2020	-332.56M
September 30, 2020	-258.64M
June 30, 2020	-271.91M
March 31, 2020	-9.748M
December 31, 2019	-5.776M
September 30, 2019	-5.762M
June 30, 2019	-5.728M

Date	Value
March 31, 2019	-5.806M
December 31, 2018	-3.127M
September 30, 2018	-2.081M
June 30, 2018	-0.9438M
March 31, 2018	-0.7894M
December 31, 2017	-1.066M
September 30, 2017	-0.9375M
June 30, 2017	-0.9242M
March 31, 2017	-0.9931M
December 31, 2016	-0.7437M
September 30, 2016	-1.038M
June 30, 2016	-0.962M
March 31, 2016	-1.208M
December 31, 2015	-1.153M
September 30, 2015	-0.8048M
June 30, 2015	-0.7758M
March 31, 2015	-0.4644M
December 31, 2014	-0.5386M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-362.07M

Minimum

Mar 2021

310.14M

Maximum

Dec 2023

-26.07M

Average

-51.29M

Median

Mar 2022

Cash from Investing (TTM) Benchmarks